CNH2: Dynamics of Integrated Socio-Environmental Systems (CNH2)
Letter of Intent Deadline Date: December 17, 2018 Program Guidelines: NSF 19-528The CNH2 Program supports research projects that advance basic scientific understanding of integrated socio-environmental systems and the complex interactions (dynamics, processes, and feedbacks) within and among the environmental (biological, physical and chemical) and human ("socio") (economic, social, political, or behavioral) components of such a system. The program seeks proposals that emphasize the truly integrated nature of a socio-environmental system versus two discrete ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=...
Source: NSF Upcoming Due Dates - November 17, 2018 Category: Science Source Type: funding
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-19-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites exploratory/developmental applications that propose transformative engineering solutions to technical challenges associated with meaningful development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-19-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices for clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and cli...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-039 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Agreement (U01) Research Projects for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development. The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally rel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2018 Category: Research Source Type: funding
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Funding Opportunity PAR-19-040 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Agreement (U01) Research Projects for research on the optimization of small molecule or biologic compounds that are excellent candidates for therapeutic development. The mission of the CounterACT Program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released f...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2018 Category: Research Source Type: funding
Division of Chemistry: Disciplinary Research Programs (CHE-DRP)
Full Proposal Window: October 1, 2018 All proposals to: Chemical Catalysis (CAT); Chemical Structure, Dynamics and Mechanisms-A (CSDM-A); Chemical Structure, Dynamics and Mechanisms-B (CSDM-B); Chemical Theory, Models and Computational Methods (CTMC); and Chemical Synthesis (SYN) Program Guidelines: NSF 18-561This solicitation applies to nine CHE Disciplinary Chemistry Research Programs: Chemical Catalysis (CAT); Chemical Measurement and Imaging (CMI); Chemical Structure, Dynamics and Mechanisms-A (CSDM-A); Chemical Structure Dynamics and Mechanisms-B (CSDM-B); Chemical Synthesis( SYN); Chemical Theory, Models and Computat...
Source: NSF Upcoming Due Dates - September 1, 2018 Category: Science Source Type: funding
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
Funding Opportunity PA-18-902 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2. to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. This FOA calls for interdisciplinary collaborations across scientific disciplines engaged in microbiome and pro/prebiotic research including, but not limited ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 14, 2018 Category: Research Source Type: funding
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-MH-19-135 from the NIH Guide for Grants and Contracts. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis and manipulation of complex circuits and provide insights into cellular interactions that underlie brain function. Critical advances in the treatment of brain disorders in human populations are hindered by our lack of ability to monitor and manipulate circuitry in safe, minimally-invasive ways. Clinical intervention with novel cell and c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 3, 2018 Category: Research Source Type: funding
Chemistry Research Experiences for Undergraduates (REU)
Full Proposal Deadline Date: August 22, 2018 Fourth Wednesday in August, Annually Thereafter Program Guidelines: PD 08-1986The Research Experiences for Undergraduates (REU) program supports active research participation by undergraduate students in any of the areas of research funded by the National Science Foundation. The NSF Division of Chemistry funds about 12-16 REU Sites a year (depending on the availability of funds) as part of the NSF-wide REU activity. Projects involve students in meaningful ways in ongoing research programs or in research projects specifically designed for the REU ...More at https://www.nsf....
Source: NSF Upcoming Due Dates - July 23, 2018 Category: Science Source Type: funding
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-853 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support research to elucidate the chemical features of non-native molecules that cross the blood-testis and/or blood-epidydimal barriers. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2018 Category: Research Source Type: funding
Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Funding Opportunity RFA-ES-18-002 from the NIH Guide for Grants and Contracts. The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes research translation), data management and analysis, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 3, 2018 Category: Research Source Type: funding
Rigorous Resources for Rigorous Research
Over two years ago, NIH rolled out a policy to enhance reproducibility of its supported research through rigor and transparency. Applicants and reviewers were required to devote more attention to four areas: the rigor of the prior research (scientific premise), the rigor of the proposed research (scientific rigor), consideration of biological variables including sex, and the authentication of key biological and/or chemical resources.
When the 21st Century Cures Act was passed later that same year, we were required, amongst other things, to assemble a working group of the Advisory Council to the NIH Director (ACD). These ex...
Source: NIH Extramural Nexus - July 2, 2018 Category: Research Authors: Mike Lauer and Patricia Valdez Tags: blog Open Mike ACD New Resources rigor Source Type: funding
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-830 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2018 Category: Research Source Type: funding
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-831 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2018 Category: Research Source Type: funding
Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional).
Notice NOT-NS-18-072 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2018 Category: Research Source Type: funding
